A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 123, Issue 1, 2005, Pages 77-81

  Walch, Katharina ^a   Grimm, Christoph ^a   Huber, Johannes C ^a   Nagele, Friedrich ^a   Kolbus, Andrea ^a   Hefler, Lukas A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gene; Plasminogen activator inhibitor; Polycystic ovary syndrome; Polymorphism

Indexed keywords

HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PERIPHERAL VEIN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; VEIN PUNCTURE;

EID: 27644573985     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.07.002     Document Type: Article

References (35)

1. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho, S. Avila, and H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrom in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434 2438
2. E.S. Knochenhauer, T.J. Key, M. Kashar-Miller, W. Waggoner, L.R. Boots, and R. Azziz Prevalence of the polycystic ovary syndrom in unselected black and white women of the Southeastern United States: a prospective study J Clin Endocrinol Metab 83 1998 3078 3082
3. H.A. Zacur Polycystic ovary syndrome, hyperandrogenism, and insulin resistance Obstet Gynecol Clin North Am 28 2001 21 33
4. R.S. Legro, A.R. Kunselman, W.C. Dodson, and B.A. Dunaif Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrom: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1999 165 169
5. J.J. Conn, H.S. Jacobs, and G.S. Conway The prevalence of polycystic ovaries in women with type 2 diabetes mellitus Clin Endocrinol 52 2000 81 86
6. J.E. Nestler, J.N. Clore, and W.G. Blackared The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome Am J Obstet Gynecol 161 1989 1095 1097
7. C.J. Glueck, S.G. Awadalla, H. Phillips, D. Cameron, P. Wang, and R.N. Fontaine Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage Fertil Steril 74 2000 394 397
8. G. Tsanadis, G. Vartholomatos, and I. Korkontzelos Polycystic ovary syndrome and thrombophilia Hum Reprod 17 2002 314 319
9. T.D. Macut, D. Micic, and G. Cvijovic Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS) Pediatr Endocrinol Metab 14 2001 1353 1359
10. I. Shimomura, T. Funahashi, and M. Takahashi Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nat Med 2 1996 800 803
11. W.U. Atiomo, S.A. Bates, J.E. Condon, S. Shaw, L.H. West, and A.G. Prentice The plasminogen activator system in women with polycystic ovary syndrome Fertil Steril 69 1998 236 241
12. Y.X. Liu Regulation of plasminogen activator system in the ovary Biol Signals Recept 8 1999 160 177
13. T.K. Nordt, K.J. Klassen, D.J. Schneider, and B.E. Sobel Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis Arterioscler Thromb 13 2003 1822 1828
14. M.C. Alessi, I. Juhan-Vague, T. Kooistra, P.J. Declerck, and D. Collen Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2 Thromb Haemost 60 1988 491 494
15. A. Stiko-Rahm, B. Wiman, A. Hamsten, and J. Nilsson Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low-density lipoprotein Arteriosclerosis 10 1990 1067 1073
16. K. Macfelda, T.W. Weiss, and C. Kaun Plasminogen activator inhibitor 1 expression is regulated by inflammatory mediators interleukin-1 alpha, tumor necrosis factor-1 alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes J Mol Cell Cardiol 34 2002 1681 1691
17. A. Hamsten, U. de Faire, and G. Walldius Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Lancet 2 1987 3 9
18. M. Ueyama, N. Kasatori, and T. Urayama Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblast Thromb Res 108 2002 235 244
19. Y.X. Liu, K. Liu, and Q. Feng Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type 1 are coordinately expressed during ovulation in rhesus monkey Endocrinology 145 2004 1767 1775
20. G.W. Smith, P.C. Gentry, B. Bao, D.K. Long, R.M. Roberts, and M.F. Smith Control of extracellular matrix remodelling within ovarian tissues: localization and regulation of gene expression of plasminogen activator inhibitor type-1 within the ovine corpus luteum J Reprod Fertil 110 1997 107 114
21. W.U. Atiomo, D. Hilton, and R. Fox Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries Gynecol Endocrinol 14 2000 162 168
22. S. Franks, N. Gharani, and D. Waterworth The genetic basis of polycystic ovary syndrome Hum Reprod 12 1997 2641 2648
23. E. Diamanti-Kandarakis, G. Palioniko, K. Alexandraki, A. Bergiele, T. Koutsouba, and M. Bartzis The prevalence of 4G5G polymorphism in plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and ist association with plasma PAI-1 levels Eur J Endocrinol 150 2004 793 798
24. C.J. Glueck, P. Wang, R.N. Fontaine, L. Sieve-Smith, T. Tracy, and S.K. Moore Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome Metabolism 48 1999 1589 1595
25. J. Hofstedt, I.L. Andersson, L. Persson, B. Isaksson, and P. Arner The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity Diabetologia 45 2002 584 587
26. M.W. Mansfield, M.H. Stickland, and P.J. Grant Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes Thromb Haemost 74 1995 1032 1034
27. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
28. H.C. Yeh, W. Futterweit, and J.C. Thornton Polycystic ovarian disease: US features in 104 patients Radiology 163 1987 111 116
29. G. Endler, W. Lalouschek, M. Exner, G. Mitterbauer, D. Häring, and C. Mannhalter The 4G/4G genotype at nucleotide position -675 in the promoter region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in patients with minor stroke than in controls Br J Haematol 110 2000 469 471
30. Expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 2003 3160 3167
31. E. Jansen, J.S.E. Laven, and H.B.R. Dommerholt Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients Mol Endocrinol 18 2004 3050 3063
32. A. Panahloo, V. Mohamed-Ali, A. Lane, F. Green, S.E. Humphries, and J.S. Yudkin Determinants of plasminogen activator inhibitor-1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene Diabetes 44 1995 37 42
33. C. Lopes, C. Dina, E. Durand, and P. Froguel PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population Diabetologia 46 2003 1284 1290
34. W.U. Atiomo, R. Fox, and J.E. Condon Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in polycystic ovary syndrome (PCOS) Clin Endocrinol 52 2000 487 492
35. B. Zietz, C. Buechler, W. Drobnik, H. Herfarth, J. Scholmerich, and A. Schaffler Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels Endocr Res 30 2004 443 453